Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures

N. Takahashi, B. R. MacDonald, J. Hon, M. E. Winkler, R. Derynck, G. R. Mundy, G. David Roodman

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Transforming growth factor-alpha (TGF-α) is synthesized by a variety of tumor cell lines and stimulates osteoclastic bone resorption in vitro. The mechanism by which TGF-α increases osteoclast activity is unknown. We used a human marrow culture system that forms osteoclast-like multinucleated cells (MNCs) to determine the effects of recombinant human TGF-α on MNC formation. Addition of 0.01 ng/ml TGF-α for the 1st week followed by 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] for the subsequent 2 wk significantly increased MNCs. Treatment of these cultures with TGF-α without later addition of 1,25(OH)2D3 did not increase MNC formation. Autoradiographic studies revealed that TGF-α stimulated proliferation of precursors for MNCs, and 1,25(OH)2D3 increased their rate of fusion into MNCs. Addition of murine epidermal growth factor (EGF) (0.1 ng/ml) followed by 1,25(OH)2D3 also significantly stimulated MNC formation. These data suggest that TGF-α and EGF may stimulate bone resorption by increasing the proliferation of osteoclast precursors, which leads to increased numbers of osteoclasts.

Original languageEnglish (US)
Pages (from-to)894-898
Number of pages5
JournalJournal of Clinical Investigation
Volume78
Issue number4
StatePublished - 1986
Externally publishedYes

Fingerprint

Osteoclasts
Transforming Growth Factor alpha
Bone Marrow
Bone Resorption
Epidermal Growth Factor
Calcitriol
human TGFA protein
Tumor Cell Line

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures. / Takahashi, N.; MacDonald, B. R.; Hon, J.; Winkler, M. E.; Derynck, R.; Mundy, G. R.; Roodman, G. David.

In: Journal of Clinical Investigation, Vol. 78, No. 4, 1986, p. 894-898.

Research output: Contribution to journalArticle

Takahashi, N. ; MacDonald, B. R. ; Hon, J. ; Winkler, M. E. ; Derynck, R. ; Mundy, G. R. ; Roodman, G. David. / Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures. In: Journal of Clinical Investigation. 1986 ; Vol. 78, No. 4. pp. 894-898.
@article{75c21221118941d99aebf9f6a48da83c,
title = "Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures",
abstract = "Transforming growth factor-alpha (TGF-α) is synthesized by a variety of tumor cell lines and stimulates osteoclastic bone resorption in vitro. The mechanism by which TGF-α increases osteoclast activity is unknown. We used a human marrow culture system that forms osteoclast-like multinucleated cells (MNCs) to determine the effects of recombinant human TGF-α on MNC formation. Addition of 0.01 ng/ml TGF-α for the 1st week followed by 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] for the subsequent 2 wk significantly increased MNCs. Treatment of these cultures with TGF-α without later addition of 1,25(OH)2D3 did not increase MNC formation. Autoradiographic studies revealed that TGF-α stimulated proliferation of precursors for MNCs, and 1,25(OH)2D3 increased their rate of fusion into MNCs. Addition of murine epidermal growth factor (EGF) (0.1 ng/ml) followed by 1,25(OH)2D3 also significantly stimulated MNC formation. These data suggest that TGF-α and EGF may stimulate bone resorption by increasing the proliferation of osteoclast precursors, which leads to increased numbers of osteoclasts.",
author = "N. Takahashi and MacDonald, {B. R.} and J. Hon and Winkler, {M. E.} and R. Derynck and Mundy, {G. R.} and Roodman, {G. David}",
year = "1986",
language = "English (US)",
volume = "78",
pages = "894--898",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "4",

}

TY - JOUR

T1 - Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures

AU - Takahashi, N.

AU - MacDonald, B. R.

AU - Hon, J.

AU - Winkler, M. E.

AU - Derynck, R.

AU - Mundy, G. R.

AU - Roodman, G. David

PY - 1986

Y1 - 1986

N2 - Transforming growth factor-alpha (TGF-α) is synthesized by a variety of tumor cell lines and stimulates osteoclastic bone resorption in vitro. The mechanism by which TGF-α increases osteoclast activity is unknown. We used a human marrow culture system that forms osteoclast-like multinucleated cells (MNCs) to determine the effects of recombinant human TGF-α on MNC formation. Addition of 0.01 ng/ml TGF-α for the 1st week followed by 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] for the subsequent 2 wk significantly increased MNCs. Treatment of these cultures with TGF-α without later addition of 1,25(OH)2D3 did not increase MNC formation. Autoradiographic studies revealed that TGF-α stimulated proliferation of precursors for MNCs, and 1,25(OH)2D3 increased their rate of fusion into MNCs. Addition of murine epidermal growth factor (EGF) (0.1 ng/ml) followed by 1,25(OH)2D3 also significantly stimulated MNC formation. These data suggest that TGF-α and EGF may stimulate bone resorption by increasing the proliferation of osteoclast precursors, which leads to increased numbers of osteoclasts.

AB - Transforming growth factor-alpha (TGF-α) is synthesized by a variety of tumor cell lines and stimulates osteoclastic bone resorption in vitro. The mechanism by which TGF-α increases osteoclast activity is unknown. We used a human marrow culture system that forms osteoclast-like multinucleated cells (MNCs) to determine the effects of recombinant human TGF-α on MNC formation. Addition of 0.01 ng/ml TGF-α for the 1st week followed by 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] for the subsequent 2 wk significantly increased MNCs. Treatment of these cultures with TGF-α without later addition of 1,25(OH)2D3 did not increase MNC formation. Autoradiographic studies revealed that TGF-α stimulated proliferation of precursors for MNCs, and 1,25(OH)2D3 increased their rate of fusion into MNCs. Addition of murine epidermal growth factor (EGF) (0.1 ng/ml) followed by 1,25(OH)2D3 also significantly stimulated MNC formation. These data suggest that TGF-α and EGF may stimulate bone resorption by increasing the proliferation of osteoclast precursors, which leads to increased numbers of osteoclasts.

UR - http://www.scopus.com/inward/record.url?scp=0023000161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023000161&partnerID=8YFLogxK

M3 - Article

VL - 78

SP - 894

EP - 898

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 4

ER -